Stock Taper
ADGM
ADAGIO MEDICAL HOLDINGS, INC.
NASDAQ
$0.51
▼ DOWN 1.79% (-0.01)

KEY STATISTICS

Market Cap$11.35 M
52w High$2.58
52w Low$0.36
Dividend Yield
Frequency
P/E-0.33
Volume230.41K
Shares Out.22.21M

COMPANY

LEADERSHIP

Todd Usen
CHIEF EXECUTIVE
Todd Usen

COMPENSATION 2026

Salary$500,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$38,608
Total$2,500,473

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 1, 2024
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
41

PRICE TARGET

Target High$3.00
Target Low$3.00
Target Median$3.00
Target Consensus$3.00

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.
NOV
11
WED

PRICE

$0.51 ▼ DOWN 1.79% (−$0.01)
$0.51$0.53$0.549:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM0.51

About Adagio Medical Holdings, Inc.

https://adagiomedical.com ↗

Adagio Medical Holdings, Inc. develops and commercializes cryoablation devices for treating cardiac arrhythmias like atrial fibrillation, flutter, and ventricular tachycardia.

INDUSTRY

Medical - Devices

A PRODUCT ADAGIO MEDICAL HOLDINGS, INC. IS KNOWN FOR

vCLAS™ Cryoablation System
vCLAS™ Cryoablation System

The vCLAS™ Cryoablation System, FDA Breakthrough Device, uses proprietary Ultra-Low Temperature Cryoablation to create durable lesions for treating ventricular tachycardia and is in pivotal U.S. clinical trials.

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

DIRECTOR
Salmon Sean
Purchase · 30.0K shares
2026-06-16
DIRECTOR
Mirsaeedi-Farahani Keyvan
Purchase · 30.0K shares
2026-06-16
DIRECTOR
GARDINER SANDRA A.
Purchase · 30.0K shares
2026-06-16
DIRECTOR
Cox James L
Purchase · 30.0K shares
2026-06-16

SECTORS PEERS

PEERPRICE
COCH$0.69COMPARE
IRIX$0.71COMPARE
CTXR$0.60COMPARE
VVOS$0.22COMPARE
CODX$1.21COMPARE
VSEE$0.02COMPARE
NVNO$10.75COMPARE